| Trial ID: | L0570 |
| Source ID: | NCT01532349
|
| Associated Drug: |
Cholecalciferol
|
| Title: |
Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease
|
| Acronym: |
D-fense
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01532349/results
|
| Conditions: |
Anemia of Chronic Kidney Disease
|
| Interventions: |
DRUG: Cholecalciferol
|
| Outcome Measures: |
Primary: Change in Serum Hepcidin With Vitamin D Intervention for Children With Chronic Kidney Disease, The null hypothesis to be tested is that Vitamin D supplementation will not be associated with a decrease in serum hepcidin over the study period. Statistical analysis will be performed as intention-to-treat., change from baseline to up to three months |
|
| Sponsor/Collaborators: |
Sponsor: Johns Hopkins University | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
34
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-05
|
| Completion Date: |
2015-04
|
| Results First Posted: |
2017-06-14
|
| Last Update Posted: |
2017-06-14
|
| Locations: |
Johns Hopkins University, Baltimore, Maryland, 21287, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01532349
|
